Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

3 Stocks to Sell Before Coronavirus Finishes What The Markets Started

Even if the economy fully reopened today, these stocks would still be in hot water, because coronavirus isn't their only problem, just the latest and biggest.

Buying PENN Stock Is Like Betting on an Inside Straight

Because this is a pandemic-fueled recession, PENN stock has unusually large risks due to its underlying core business being completely gutted.

Why It’s Hard to Bet on MGM Resorts

MGM stock is looking for a catalyst. Its new BetMGM app was showing promise but is now being ravaged as sports betting is on hold.

The ‘Essential’ Problem for Aurora Stock

With all the challenges facing Aurora stock, the coronavirus pandemic was the last thing it needed. Moreover, Aurora Cannabis can't mitigate the pain effectively because marijuana is a non-essential product in its home market.

Buying DAL Stock Is About Psychology More Than Economics

In the wake of the coronavirus pandemic, a bet on DAL stock requires investors to understand how buyer behavior will impact demand.